Nationwide Fund Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-53,300
| Closed | -$1.81M | – | 210 |
|
|
2017
Q3 | $1.81M | Buy |
53,300
+900
| +2% | +$30.5K | 0.01% | 1489 |
|
|
2017
Q2 | $1.79M | Buy |
52,400
+900
| +2% | +$30.7K | 0.01% | 1480 |
|
|
2017
Q1 | $1.6M | Buy |
51,500
+1,900
| +4% | +$59.2K | 0.01% | 1508 |
|
|
2016
Q4 | $1.36M | Sell |
49,600
-2,400
| -5% | -$65.6K | 0.01% | 1612 |
|
|
2016
Q3 | $1.71M | Sell |
52,000
-1,600
| -3% | -$52.6K | 0.01% | 1476 |
|
|
2016
Q2 | $1.62M | Sell |
53,600
-4,000
| -7% | -$121K | 0.01% | 1468 |
|
|
2016
Q1 | $1.62M | Sell |
57,600
-292,070
| -84% | -$8.22M | 0.01% | 1453 |
|
|
2015
Q4 | $11.9M | Buy |
349,670
+2,600
| +0.7% | +$88.3K | 0.05% | 494 |
|
|
2015
Q3 | $11M | Sell |
347,070
-61,700
| -15% | -$1.96M | 0.05% | 485 |
|
|
2015
Q2 | $13M | Buy |
408,770
+10,560
| +3% | +$336K | 0.05% | 450 |
|
|
2015
Q1 | $13.6M | Buy |
398,210
+26,400
| +7% | +$903K | 0.05% | 449 |
|
|
2014
Q4 | $13.1M | Buy |
371,810
+170,600
| +85% | +$6M | 0.06% | 438 |
|
|
2014
Q3 | $7.19M | Sell |
201,210
-600
| -0.3% | -$21.4K | 0.03% | 752 |
|
|
2014
Q2 | $7.5M | Buy |
+201,810
| New | +$7.5M | 0.03% | 744 |
|
|
2014
Q1 | – | Sell |
-103,000
| Closed | -$3.06M | – | 3135 |
|
|
2013
Q4 | $3.06M | Buy |
103,000
+1,200
| +1% | +$35.6K | 0.01% | 1231 |
|
|
2013
Q3 | $2.64M | Buy |
+101,800
| New | +$2.64M | 0.01% | 1265 |
|